The Corporate Reputation of Pharma Industry - The Patient Perspective in 2015 - Nordic Edition

  • ID: 3942532
  • Report
  • Region: Denmark, Faroe Islands, Finland, Greenland, Iceland, Norway, Sweden
  • 55 pages
  • PatientView
1 of 4

FEATURED COMPANIES

  • AbbVie
  • AstraZeneca
  • Bristol-Myers Squibb
  • Leo Pharma
  • Merck & Co
  • Pfizer
  • MORE

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 147 Nordic patient groups in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the Nordic pharma industry during 2015, as well as the performance of 20 pharma companies for six key indicators that influence corporate reputation. Results are compared with those of the previous year.

The report also offers, as case studies, survey responses from two companies: Leo Pharma and Lundbeck, which explain what they are doing on the subject of global patient centricity, and comments about its relationships with patient groups.

Profiles Of the 13 Companies, According To the Patient Groups in the Nordic Region Familiar with These Companies, or Have Worked With Them

Each profile contains

Company Background Information

  •     Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. Increase in revenue over the previous year or decrease in revenue.
  •     The profiled company’s main treatment subject areas (and areas of R&D).
  •     A mission statement from the profiled company.

How the Company Has Performed At Six Indicators of Corporate Reputation

  •         The profiled company’s performance at the six indicators of corporate reputation in 2015, according to the patient groups in the Nordic Region familiar with the company.
  •         The profiled company’s performance at the six indicators of corporate reputation, according to the patient groups in the Nordic Region that have worked with the company.
  •         How the profiled company performed in the Nordic Region for different therapy areas, compared with the company’s averages in the Nordic Region across all therapy areas in 2015.
  •         How the profiled company performed in the Nordic Region for different countries/regions, compared with the company’s averages in the Nordic Region in 2015.

How the Company Ranks For Corporate Reputation Compared With Other Companies

  • The profiled company’s rankings in the Nordic Region in 2015 for the six indicators of corporate reputation, compared with 12 other companies
    The profiled company’s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 47 other companies

Profile of the Patient Groups Familiar with the Company

  •     Other companies that partner with a significant number of the profiled company’s partner patient groups.
  •     The therapy areas and countries of the patient groups familiar with the profiled company.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie
  • AstraZeneca
  • Bristol-Myers Squibb
  • Leo Pharma
  • Merck & Co
  • Pfizer
  • MORE

ABOUT THIS REPORT 

WHAT DID PATIENT GROUPS IN THE NORDIC REGION SAY ABOUT PHARMA IN 2015?

  • Summary of the industry-wide findings

SOME POINTS ABOUT THE NORDIC CORPORATE RANKINGS 

WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION?

A FEW COMMENTS FROM PATIENT GROUPS IN THE NORDIC REGION, 2015 

CASE STUDIES: PATIENT-GROUP RELATIONS AND PATIENT CENTRICITY AT …

  • Lundbeck
  • Leo Pharma

METHODOLOGY OF THE PATIENT-GROUP SURVEY 

QUESTIONNAIRE FOR PHARMA COMPANIES 2015 

APPENDIX 1:  Data on how patient groups in the Nordic region see the pharma industry in 2015
APPENDIX 2:  Rankings of the 20 pharma companies for each of the 6 indicators of corporate reputation, as perceived by patient groups in the Nordic region in 2015
APPENDIX 3: Profiles of the 20 companies
APPENDIX 4: Profiles of the 147 respondent patient groups

LIST OF TABLES AND CHARTS—BASED ON THE VIEWS OF PATIENT GROUPS IN THE NORDIC REGION
Percentage of patient groups in the Nordic region claiming familiarity with the company 
Percentage of patient groups in the Nordic region claiming familiarity, and which also worked with the company 
% of patient groups (by geographic region) stating that pharma is “Excellent” or “Good” at BEING PATIENT CENTRIC
% of patient groups (by geographic region) stating that pharma is “Excellent” or “Good” at PROVIDING HIGH QUALITY PATIENT INFORMATION
% of patient groups (by geographic region) stating that pharma is “Excellent” or “Good” at HAVING A GOOD RELATIONSHIP WITH THE MEDIA
Final ranking of pharma companies for corporate reputation in 2015, according to patient groups based in Scandinavia, v. final ranking in Scandinavia in 2015
The percentage of patient groups from four Nordic countries that said pharma had an “Excellent” or “Good” corporate reputation in 2015
If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option
How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015?
What do you think has happened to the corporate reputation of the pharma industry over the past five years? 
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups in the Nordic region)?
Companies with the most effective patient-centred strategy (rankings of 20 companies, 2015) 
Companies providing the best high-quality patient information (rankings of 20 companies, 2015) 
Companies with the best record on patient safety (rankings of 20 companies, 2015) 
Companies with the most-useful high-quality products (rankings of 20 companies, 2015) 
Companies with the best record of transparency (rankings of 20 companies, 2015) 
Companies with the best record on integrity (rankings of 20 companies, 2015) 
Rankings of the 20 pharmaceutical companies in 2015, ALPHABETIC ORDER 
Rankings of the 20 pharmaceutical companies in 2015, HIGHEST TO LOWEST 
Profile of 2015’s 147 respondent patient groups based in the Nordic region—by country 
Profile of 2015’s 147 respondent patient groups based in the Nordic region—by therapy area 
Geographic remit of 2015’s 147 respondent Scandinavian patient groups

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie
  • Actavis
  • Amgen
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • GSK
  • Janssen
  • Leo Pharma
  • Lilly
  • Lundbeck
  • Merck & Co
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sandoz
  • Sanofi
  • Takeda
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll